This study was conducted to determine how transesophageal echocardiography (TEE) guides intraoperative decision making during myocardial revascularization. Although its usefulness in influencing clinical decision making during cardiac valvular surgery is well documented, the clinical utility of TEE in patients undergoing myocardial revascularization is less clear. We studied the performance of five community-based, full-time cardiac anesthesiologists during 75 surgical procedures. All patients were monitored with radial artery and pulmonary artery catheters as well as biplane TEE. Immediately after each clinical intervention, the anesthesiologist was asked to determine how real-time TEE influenced the therapy, which single monitor was most influential, and why each therapy was initiated. Of the 584 interventions, TEE was the single most important guiding factor in 98 instances (17%). Interventions involving fluid administration contributed to 277 of 584 (47%) of the total clinical decisions. TEE was the most important monitor influencing fluid administration in 82 of 277 instances (30%), versus the pulmonary artery catheter in 20 of 277 instances (7%). TEE was the single most important monitor in guiding other therapies as follows: antiischemic therapy, 8 of 38 = 21%; vasopressor or inotrope administration, 4 of 115 = 3%; vasodilator therapy, 1 of 38 = 3%; antiarrhythmic medications, 0 of 16 = 0%; and depth of anesthesia, 1 of 72 = 1%. In 2 of 75 patients (3%), critical surgical interventions were made solely on the basis of TEE. Also, TEE was found to act in concert with other monitors in 254 of 584 interventions (43%) . TEE is often influential in guiding decision making in myocardial revascularization when incorporated as a routine monitor in the intraoperative setting. Information from TEE has been most commonly used to guide the management of fluid administration and institution of antiischemit therapy. In a small subset of patients, TEE appears to be useful in guiding critical surgical interventions. (Anesth Analg 1996; 82:113945) M dial revascularization procedures are performed at a yocardial revascularization is the most comcost of more than 10 billion dollars (l-3). Due to changing patient demographics and the increased use monly performed cardiac operation in the of angioplasty and prolonged medical therapy, patients presenting for myocardial revascularization are United States. Annually, over 400,000 myocarolder and have more compromised ventricular function than their predecessors (4). Surgical and anesthetic search, based on the assumption that more sensitive and/or accurate monitoring may aid patient management and, possibly, improve outcome. One example is transesophageal echocardiography (TEE), which is increasingly used intraoperatively as a monitor of ventricular function and volume. Although the influence of TEE on clinical decision making during cardiac valvular surgery is well documented (5-8), its clinical utility in patients undergoing myocardial revascularization is less clear. One potential advantage of TEE is that regional wall-motion abnormalities detected by TEE are more sensitive markers of myocardial ischemia in the intraoperative setting than multilead electrocardiography (9). Additionally, new postbypass regional wall-motion abnormalities detected by TEE 01996 by the International Anesthesia Research Society 0003-2999 / 96/ $5.00 Anesth Analg 1996;82:113945 may be predictive of adverse cardiac outcomes (10). However, the echocardiographic data in previous studies have been analyzed off-line. Since clinical decision making requires on-line interpretation of monitoring data, it is critical to understand how intraoperative TEE data actually guide real-time decision making. If information from TEE monitoring is prognostically important but the data are infrequently used to guide real-time clinical decision making, then efforts to optimize the use of TEE data in this setting are necessary. Accordingly, the present study investigates the utility of TEE as a real-time continuous monitoring device in assessing intraoperative global and regional left ventricular function in patients undergoing myocardial revascularization.
Methods
Approval from the Institutional Human Research Committees was obtained prior to the study of the clinical management of 75 patients undergoing elective myocardial revascularization between February and October 1992 at Kaiser Permanente Medical Center, San Francisco. Inclusion in the study required that patients be undergoing myocardial revascularization without concomitant cardiac procedures. The experience and training of these anesthesiologists involved have been described previously in Part I of this study (11). Anesthetic and surgical management were not dictated by this protocol. However, anesthesiologists were requested to control intraoperative hemodynamits to within ? 20% of preoperative values. Standard monitoring included five-lead electrocardiography (ECG), arterial and pulmonary artery (PA) catheters, as well as TEE. After induction of anesthesia and intubation of the trachea, a biplane TEE probe, 9-mm flexible gastroscope tipped with two 5.0-MHz, miniaturized phased array ultrasound transducers (Hewlett Packard, Andover, MA) was inserted into the esophagus and advanced to achieve biplane imaging of the four cardiac chambers and color flow Doppler imaging of valvular function. A complete examination of the left and right ventricular size and function and valvular function were obtained. After this baseline examination, a short-axis view of the left ventricle at the level of the midpapillary muscle was monitored continuously until skin closure. In addition, the transgastric longitudinal view was obtained every 10 min throughout surgery.
To facilitate recognition of intraoperative changes in left ventricular function, we used a quad screen display that allowed the juxtapositioning of the baseline echocardiograms (the short-axis and transgastric longitudinal views from one cardiac cycle played continuously) with subsequent echocardiograms on the same video screen. Every 10 min, the quad screen system was updated with new images (real-time) of the short-and long-axis views, using the previous images as comparison. These quad screen images were acquired in tine-loop format.
To determine how information from various monitors influenced clinical decision making, every clinical or major surgical intervention was recorded by a physician investigator (BDB) who did not provide patient care or contribute to the intraoperative real-time analysis of TEE data. Examples of interventions are shown in Table 1 . Immediately after an intervention, the anesthesiologist was asked whether the decision to intervene was based on data derived from TEE, ECG, or radial or PA catheter monitoring. For each intervention related to information obtained from TEE monitoring, anesthesiologists were further asked to rank whether the TEE data were "the driving force," or "supportive. " "Driving force" indicated that it was the sole indicator of the need for therapeutic intervention, e.g., administration of nitroglycerin intravenously for the treatment of a new regional wall-motion abnormality detected by TEE in the absence of ECG indicators of ischemia and of hemodynamic changes. A "supportive" influence was defined as the use of TEE data in conjunction with primary data from one of the other (conventional) intraoperative monitors in the decision to intervene, e.g., administration of additional anesthetic for arterial hypertension indicated primarily by the radial arterial monitor but in the presence of TEE evidence of good left ventricular function. Monitors having little or no influence on a therapeutic intervention were defined as "noninfluential," e.g., defibrillation for ventricular fibrillation based solely on ECG data identified arterial catheter or TEE monitoring as "noninfluential."
Clinical data, including ECG and arterial and PA catheter data, were continuously evaluated by the anesthesiologists in the intraoperative period. PA catheter data included not only the absolute pressure values, but also pressure wave forms, cardiac output, and calculated systemic vascular resistance data. Cardiac output measurements were obtained by the anesthesiologists as clinically indicated. Data from TEE were evaluated at least every 10 min.
Patient outcomes were assessed by 12-lead ECG and creatine phosphokinase-MB isoenzyme levels which were obtained preoperatively (control) and daily for the first two postoperative days. Adverse major outcomes were defined as myocardial infarction (increase of creatine phosphokinase-MB isoenzymes to ~50 U/L and the development of Q waves on postoperative ECG), ventricular failure, or cardiac death (10).
The difference in the number of interventions between the monitors was assessed by the binomial test (12). Specifically, we compared the rates at which two monitors were named for a specific intervention by testing whether the rates were different from those resulting from a binomial distribution with equal probabilities for both monitors. For example, of 102 fluid bolus interventions based on either TEE or PA catheter, 20 were based on PA catheter and 82 on TEE. A binomial with IZ = 102 and P = 0.5 (equal probabilities) would produce this large a difference in rates with a probability of 0.0001, which is therefore the two-sided P-value for rejecting the null hypothesis that the two rates are equal.
Differences among the five anesthesiologists were measured using either analysis of variance or the 2 test as appropriate.
Results
The demographic
and clinical data of the study patients are provided in Table 2 . The majority of patients were presenting for first-time cardiac surgery, had relatively normal left ventricular function (mean preoperative ejection fraction was 61% + 14%), and stable angina. A total of 584 clinical interventions was made in these 75 patients (Table 3) . The most frequently observed intervention was the administration of fluid bolus (277 of 584 = 47% of all interventions).
Overall, TEE was the most important guiding factor in 98 of 584 (17%) instances (Table 3) . TEE was the most important monitor in guiding these therapies as follows: fluid administration, 82 of 277 = 30%; antiischemic therapy, 8 of 38 = 21%; vasopressor or inotrope administration, 4 of 115 = 3%; vasodilator therapy, 1 of 38 = 3%; antiarrhythmic medications, 0 of 16 = 0%; and depth of anesthesia, 1 of 72 = 1%. Additionally, critical events which were influenced by intraoperative TEE monitoring occurred in 2 of 75 patients (3%): one patient required emergent return to cardiopulmonary bypass to repair a graft that kinked upon chest closure (there was no ECG evidence of ischemia, and the diagnosis was based on the development of a new regional wall-motion abnormality on TEE); the second patient required the addition of retrograde in addition to antegrade cardioplegia due to previously unrecognized aortic insufficiency. The number of interventions differed significantly by monitor. Compared with information from ECG and radial and PA catheter monitoring, TEE influence on the decision to administer bolus fluids was greater than that of the other modalities (Table 3) ; specifically, the number of bolus fluid interventions based on TEE data was fourfold higher than that due to PA catheter monitoring (P < 0.0001). In contrast, the administration of vasopressors and vasodilators, and changes in the depth of anesthesia, were based predominantly on changes in the systemic arterial blood pressure detected by radial arterial monitoring. ECG facilitated more antiischemic therapeutic interventions (18 of 38; 47%) than TEE (8 of 38; 21%); P < 0.05.
We also examined whether interventions were based on TEE monitoring in concert with other monitor(s), i.e., whether the influence of TEE was supportive. Overall, 254 of 584 = 43% of interventions were based on supportive data from TEE. The administration of fluid bolus and vasopressor therapy were the most commonly observed interventions based on supportive TEE data (Figure 1) .
The distribution of the number of interventions performed by anesthesiologist was as follows: 117 (20%), CARDIOVASCULAR ANESTHESIA 1996;82 1139-45 127 (22%), 97 (17%), 143 (24%), and 100 (17%), respectively, among the five clinicians. Anesthesiologists differed in their overall use of the clinical monitors in guiding clinical interventions; P = 0.0001 (Figure 2) . For example, anesthesiologists No. 1 and No. 5 were more similar in their use of TEE than the other three anesthesiologists. However, all five anesthesiologists were similar in using TEE more frequently than ECG in guiding clinical interventions.
We used three criteria to indirectly evaluate the "appropriateness" of the clinical interventions being made in the study: hemodynamic control; conditions in which fluid administration, vasopressor and inotropit therapies were being instituted; and patient outcome (as compared with a group of historical controls from the same institution). Hemodynamics were generally well controlled in these 75 patients with no major differences among anesthesiologists. The percentages of monitored period in which tachycardia (heart rate 2 90 bpm) occurred was 16%, systolic hypotension (systolic blood pressure < 80 mm Hg) 4%, and systolic hypertension (systolic blood pressure 2 160 mm Hg) 0.8%. When fluid boluses were being administered, the mean PA diastolic pressure was significantly lower than the values measured when vasopressor therapy was being instituted (Figure 3) . In addition, the mean systolic blood pressure ( ~SEM in mm Hg) was significantly lower during inotropic (84 i ll), vasopressor (82 ? 3), or fluid bolus therapies (90 t 2) than during vasodilator therapy (143 +-6), increases in anesthetic depth (142 t 5), or antiischemic therapy (110 -t 5); P < 0.0001.
Adverse outcomes occurred in 4 of 75 (5%) patients. Three of these four patients developed nonfatal postoperative myocardial infarction and the fourth patient died in the intensive care unit. No patient developed ventricular failure. These outcome rates were not significantly different from those reported in the same year for a larger cohort undergoing isolated coronary artery bypass graft surgery (myocardial infarction rate of 2.7% and mortality rate within 30 days 1.59%, n = 440; P = 0.93) (Kaiser Permanente Medical Center, San Francisco, cardiovascular surgery data).
Discussion
Our study indicates that 17% of intraoperative clinical interventions were influenced predominantly by information obtained from TEE. The majority of the interventions influenced by TEE monitoring involved fluid administration or antiischemic therapy. An additional 43% of interventions were based on supportive data from TEE monitoring.
There is no similar study which examines the clinical usefulness of TEE in impacting decision making in patients undergoing myocardial revascularization. In other settings, such as cardiac valvular surgery, TEE has been useful in guiding patient selection (6), changing surgical plan (5), assessing the residual mitral regurgitation after mitral valve repair (7, (13) (14) (15) (16) , and quantifying the degree of mitral valve regurgitation (8, 17) . In noncardiac surgery, one study reported that the "routine" use of TEE did not predict postoperative cardiac complications in high-risk surgical patients (18). In that study, the left ventricle was monitored at the short-axis level for detection of regional wallmotion abnormalities.
The treating clinicians were blinded to the information from the TEE monitor and relied only on routine clinical monitors such as the ECG monitor. One reason why information from TEE was not predictive of postoperative cardiac complications in the latter study may be that the incidence of myocardial ischemia was highest in the postoperative period, after removal of the TEE probe, resulting in the ECG being the only monitor available to detect ischemia. The other potential limitation of the study by Eisenberg et al. (18) is that other uses of TEE, such as monitoring for intravascular volume status, valvular competence, and global left ventricular function, were not explored. Additionally, it was not possible to determine how TEE monitoring may have altered clinical decision making in these patients because the treating clinicians were blinded to the TEE information.
Although our study focuses on the clinical utility of TEE, we also have the opportunity to assess the usefulness of other intraoperative monitors in guiding intraoperative clinical decisions in patients undergoing elective myocardial revascularization. The anesthesiologists being studied have adopted both PA catheter and TEE as their routine intraoperative monitors. However, PA catheter data overall were used less frequently than TEE to guide fluid therapy. It is well known that pulmonary wedge pressure correlates poorly with left ventricular volume when there is an alteration in the ventricular pressure-volume relationship during and after myocardial reperfusion. Because of the difficulty in clinically determining ventricular compliance, using left ventricular pressure or pulmonary wedge pressure alone to assess left ventricular volume can be inaccurate. Monitoring left ventricular dimension by TEE may provide a more sensitive measurement of changes in preload than PA pressure. Our study also demonstrates that PA catheter data were used infrequently to guide antiischemic therapy, a finding consistent with previous results demonstrating that PA catheterization is not a sensitive monitor for ischemic changes (19, 20) .
Of all the clinical interventions made, fluid therapy was the one most often influenced by TEE. However, TEE also was essential to intervention in two critical situations which could not have been detected by other monitors. Of more importance perhaps is the supportive role of TEE. When combined with information from other monitors, TEE commonly influenced clinical decision making, as indicated by the 43% of cases in which clinicians judged its effect to be "supportive." This finding suggests that the overall clinical usefulness of TEE may be underestimated, because it is likely that information from different monitors act in concert in influencing most intraoperative clinical decisions.
We found that the decision to begin antiischemic therapy was more than twice as likely to be based on ECG than TEE information.
These results are at variance with data from experimental and clinical studies indicating that regional mechanical changes are more sensitive markers of ischemia and occur earlier than ECG ST-segment changes indicative of ischemia (21-24).
This discrepancy raises the question of whether regional wall-motion abnormalities can be detected easily by clinicians in the intraoperative setting. Another explanation why antiischemic therapy was more often guided by ECG than by TEE might be that the anesthesiologists had more experience in treating electrocardiographic ischemia than regional wall-motion abnormalities.
As a result, they might be more likely to institute therapy based on ECG than TEE changes. Additionally, since there are nonischemit etiologies of regional ventricular dysfunction such as myocardial stunning, the appearance of a new regional wall-motion abnormality (especially during reperfusion) might necessitate alternate therapy such as inotropic support.
There are several limitations to this study. First, requiring that the participating anesthesiologists justify the clinical interventions performed and report which monitor was most influential for each and every intervention per protocol is a departure from common clinical practice. Although the actual use of TEE was not restricted (anesthesiologists were free to assess TEE information whenever they wished), it is still possible that these anesthesiologists, in practice, assess TEE images less often than the present protocol required. Therefore, our results may have overestimated the clinical utility of TEE if it is used less frequently than required by the present protocol.
Second, we have no direct data demonstrating whether the clinical interventions made were indeed "appropriate." However, the tight intraoperative hemodynamic control and the general successful outcome of this studied cohort indirectly suggest that these patients were appropriately managed. Third, we studied clinical decision making for a group of patients with relatively normal ventricular function and the study sample size is relatively small. Therefore, the study results may not be directly generalizable to patients with more severely compromised ventricular function or patients undergoing noncardiac surgery.
Lastly, we did not examine other diagnostic uses of TEE such as the detection of aortic atheroma. The overall clinical utility of TEE may have increased if additional uses were examined.
In conclusion, we found that in a group of patients undergoing elective myocardial revascularization, TEE is frequently influential in guiding clinical decision making, especially in the management of fluid administration.
In a subset of patients, TEE appears to be useful in guiding critical surgical interventions. Whether intraoperative monitoring alters patient outcomes needs to be addressed by a prospective, randomized trial examining the effect of each critical intraoperative monitor on clinical management and outcome. 
